{"nctId":"NCT01231347","briefTitle":"QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas","startDateStruct":{"date":"2011-04-07","type":"ACTUAL"},"conditions":["Adenocarcinoma of the Pancreas","Advanced Solid Tumors","Cancer","Cancer of Pancreas","Cancer of the Pancreas","Metastases","Metastatic Cancer","Metastatic Pancreatic Cancer","Pancreas Cancer","Pancreatic Cancer","Bone Metastases","Endocrine Cancer","Oncology","Oncology Patients","Solid Tumors","Advanced Malignancy"],"count":800,"armGroups":[{"label":"Placebo + gemcitabine","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Drug: gemcitabine"]},{"label":"AMG 479 12 mg/kg dose + gemcitabine","type":"EXPERIMENTAL","interventionNames":["Drug: AMG 479","Drug: gemcitabine"]},{"label":"AMG 479 20 mg/kg + gemcitabine","type":"EXPERIMENTAL","interventionNames":["Drug: AMG 479","Drug: gemcitabine"]}],"interventions":[{"name":"AMG 479","otherNames":[]},{"name":"Placebo","otherNames":[]},{"name":"AMG 479","otherNames":[]},{"name":"gemcitabine","otherNames":["Gemzar"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Untreated metastatic adenocarcinoma of the pancreas\n* Adequate hematologic, renal and liver function\n* Eastern Cooperative Oncology Group (ECOG) 0 or 1\n\nExclusion Criteria:\n\n* Prior chemotherapy or radiotherapy for pancreatic cancer\n* Central nervous system metastases\n* External biliary drain","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Determine if the Treatment of AMG 479 at 12 mg/kg and/or 20 mg/kg in Combination With Gemcitabine Improves Overall Survival as Compared With Placebo in Combination With Gemcitabine in Subjects With Metastatic Adenocarcinoma of the Pancreas","description":"The primary endpoint of the study was OS, defined as the time from randomization to death.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.0","spread":null},{"groupId":"OG001","value":"7.1","spread":null},{"groupId":"OG002","value":"7.2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":33,"n":317},"commonTop":["Nausea","Neutropenia","Thrombocytopenia","Fatigue","Decreased Appetite"]}}}